CLINICAL_TRIALS trial_result · 2025-02-18

Clinical Trial Update: Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease [Phase 2]

Phase 2 trial evaluating the efficacy and safety of vamifeport (VIT-2763) in sickle cell disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vifor (International) Inc. | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-02-18